Most seriously, FDA investigators found a great many instances of cheating in the Boston center where they began their review. Dr. Fauci’s decision to terminate the trials prevented the inspectors from investigating the other eleven centers, which were, presumably, just as dreadful as Boston. After agonizing over whether to exclude data from the delinquent Boston center or from patients with protocol violations, the FDA decided to exclude nothing: “False data were retained. Garbage was thrown in with the good stuff.” The FDA argued that if all the false data were excluded, there would be an
...more
